Iptacopan (LNP023) Mechanism of Action
Iptacopan is an oral, investigational inhibitor of factor B, a key component of the proximal alternative pathway of the complement system.
Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
PNH = paroxysmal nocturnal hemoglubinuria.
This site may contain information of products which have not been authorized in your country.
Please note that the following content is exclusively addressed to healthcare professionals and its correct interpretation requires specialized training.
Are you a healthcare professional?